Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials

Abstract Purpose: Response Evaluation Criteria in Solid Tumors (RECIST) evaluation does not take into account the pretreatment tumor kinetics and may provide incomplete information about experimental drug activity. Tumor growth rate (TGR) allows for a dynamic and quantitative assessment of the tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Charles Ferté, Marianna Fernandez, Antoine Hollebecque, Serge Koscielny, Antonin Lévy, Christophe Massard, Rastislav Balheda, Brian M. Bot, Carlos Gomez‐Roca, Clarisse Dromain, Samy Ammari, Jean‐Charles Soria
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Acesso em linha:https://doi.org/10.1158/1078-0432.ccr-13-2098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!